2) ACCP/SCCM Consensus Conference Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
3) 相川直樹:SepsisからSIRSへ.外科診療 1994; 36: 1073-5.
4) Okusawa S, Dinarello CA, Yancey KB, et al: C5a induction of human interleukin-1; Synergistic effect with endotoxin or interferon-γ. J Immunol 1987; 139: 2636-40.
5) Ikejima T, Okusawa S, Dinarello C, et al: Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance and interleukin-1 from human mononuclear cells. J Infect Dis 1988; 158: 1017-25.